New England Securities’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$255K Sell
4,709
-3,319
-41% -$185K 0.09% 227
2014
Q3
$454K Buy
8,028
+169
+2% +$9.49K 0.16% 153
2014
Q2
$434K Buy
7,859
+2,636
+50% +$144K 0.15% 176
2014
Q1
$283K Sell
5,223
-500
-9% -$25.9K 0.11% 205
2013
Q4
$273K Buy
5,723
+786
+16% +$35.9K 0.11% 215
2013
Q3
$224K Sell
4,937
-325
-6% -$14.8K 0.11% 204
2013
Q2
$233K Buy
+5,262
New +$235K 0.16% 152

Other funds holding MRK

New England Securities's MRK Position: Q4 2014 in Review

New England Securities reduced its Merck (MRK) stake by 41% in Q4 2014, selling an estimated $185K and leaving 4,709 shares worth $255K. The position accounts for 0.09% of the portfolio, ranked #227.

New England Securities first reported a position in MRK in Q2 2013 and has held it in 7 quarters since. The position peaked at $454K in Q3 2014. 1,722 funds tracked by Wall St. Rank hold MRK as of Q4 2014.

  • New England Securities held 4,709 shares of Merck worth $255K as of Q4 2014.
  • New England Securities sold 3,319 Merck shares in Q4 2014, an estimated $185K.
  • Merck made up 0.09% of New England Securities's portfolio in Q4 2014, its #227 holding.
  • New England Securities first reported a position in Merck in Q2 2013 and has held it in 7 quarters since.
  • New England Securities's Merck position peaked at $454K in Q3 2014.
  • 1,722 funds tracked by Wall St. Rank held Merck as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.